Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (VRTX – Research Report) and Apellis ...

RBC Capital raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $420 from $408 and keeps a Sector Perform rating on the shares.

Shares of Vertex Pharmaceuticals Inc. VRTX slipped 1.60% to $484.82 Monday, on what proved to be an all-around favorable ...

Vertex Pharmaceuticals Inc. closed 5.23% below its 52-week high of $519.88, which the company achieved on November 8th.

Vertex's cloud growth momentum remains strong, with a 27% y/y increase in 4Q24. Read more to see why I upgrade VERX stock ...

Vertex Pharmaceuticals continues to see patients with sickle cell disease start the process to receive its Casgevy therapy, ...

Pilgrim, one of India's fastest-growing beauty and personal care brands, has successfully raised ₹200 crore in a mix of primary and secondary funding rounds. The round saw participation from existing ...

The retailer said it is adding Margaret Getchell, “the trailblazing executive who transformed Macy’s in the 19th century” and was reportedly responsible for its red star logo, to the adaption.

Google’s Chirp 3 AI model supports text-to-speech Chirp 3 offers 248 distinct voices with eight speaker options Google says AI-generated voices are useful for podcast narration ...

Woollen rugs that resemble the side profiles of human faces are among 11 new products featured on Dezeen Showroom.

In the latest development, Google today announced that it would be adding Chirp 3 — its speech-to-text and HD text-to-speech models — to its Vertex AI development platform starting next week.